Short Interest in Corindus Vascular Robotics Inc (NYSEAMERICAN:CVRS)

[ad_1]

Corindus Vascular Robotics Inc (NYSEAMERICAN:CVRS) saw a significant growth in short interest in April. As of April 15th, there was short interest totalling 14,433,050 shares, a growth of 6.4% from the March 29th total of 13,569,380 shares. Based on an average daily volume of 1,229,430 shares, the days-to-cover ratio is currently 11.7 days. Approximately 12.2% of the shares of the stock are short sold.

In other Corindus Vascular Robotics news, major shareholder Hudson Executive Capital Lp bought 2,899,391 shares of the business’s stock in a transaction on Tuesday, March 12th. The stock was bought at an average price of $1.38 per share, with a total value of $4,001,159.58. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Louis A. Cannon bought 573,798 shares of the business’s stock in a transaction on Tuesday, March 12th. The shares were acquired at an average cost of $1.38 per share, with a total value of $791,841.24. The disclosure for this purchase can be found here. Insiders have acquired 3,483,189 shares of company stock worth $4,811,001 in the last quarter.

Several institutional investors and hedge funds have recently bought and sold shares of the company. Canton Hathaway LLC acquired a new stake in shares of Corindus Vascular Robotics during the first quarter worth about $63,000. Jane Street Group LLC acquired a new position in Corindus Vascular Robotics in the 4th quarter valued at about $36,000. HRT Financial LLC acquired a new position in Corindus Vascular Robotics in the 4th quarter valued at about $44,000. Millennium Management LLC increased its position in Corindus Vascular Robotics by 1.0% in the 4th quarter. Millennium Management LLC now owns 7,088,692 shares of the medical equipment provider’s stock valued at $5,955,000 after acquiring an additional 68,250 shares during the period. Finally, First Republic Investment Management Inc. acquired a new position in Corindus Vascular Robotics in the 1st quarter valued at about $122,000.

Corindus Vascular Robotics stock opened at $2.18 on Friday. Corindus Vascular Robotics has a 1-year low of $0.70 and a 1-year high of $2.54.

Corindus Vascular Robotics (NYSEAMERICAN:CVRS) last posted its earnings results on Tuesday, March 12th. The medical equipment provider reported ($0.04) EPS for the quarter, hitting the Zacks’ consensus estimate of ($0.04). The firm had revenue of $4.67 million for the quarter, compared to analyst estimates of $5.60 million.

TRADEMARK VIOLATION WARNING: “Short Interest in Corindus Vascular Robotics Inc (NYSEAMERICAN:CVRS) Expands By 6.4%” was first published by Finance Daily and is the property of of Finance Daily. If you are accessing this report on another domain, it was illegally stolen and reposted in violation of US and international trademark and copyright legislation. The correct version of this report can be viewed at https://www.fidaily.com/2019/05/03/corindus-vascular-robotics-inc-cvrs-short-interest-up-6-4-in-april.html.

About Corindus Vascular Robotics

Corindus Vascular Robotics, Inc designs, manufactures, and sells robotic-assisted systems for use in interventional vascular procedures in the United States and internationally. The company offers CorPath system, a medical device with robotic-assisted precision for coronary and peripheral interventional procedures.